Acetyl Hexapeptide-8 vs Leuphasyl
A side-by-side research comparison of Acetyl Hexapeptide-8 and Leuphasyl across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Acetyl Hexapeptide-8 | Leuphasyl |
|---|---|---|
| Full name | Acetyl Hexapeptide-8 (Argireline Advanced) | Leuphasyl (Pentapeptide-18) |
| Category | Skin & Anti-Aging | Skin & Anti-Aging |
| Status | Research compound | Research compound |
| Mechanism | Same SNARE complex competition as argireline with acetyl modification for improved stability and cellular uptake. | Binds enkephalin receptors on neuronal membranes, reducing calcium influx and neurotransmitter release at the presynaptic level. Works upstream of argireline. |
| Molecular weight | 889 Da | 599.7 Da |
| Half-life | 10-14 hours | 6-10 hours (topical) |
| Bioavailability | Improved (topical, acetylated) | Moderate (topical) |
| Typical dose | 5-10% | 3-5% solution |
| Frequency | 2x daily | 2x daily |
| Route | Topical | Topical |
Acetyl Hexapeptide-8 reported benefits
- Improved stability
- Expression wrinkle reduction
- Preventative anti-aging
- Compatible with most formulations
Leuphasyl reported benefits
- Complements argireline action
- Reduces muscle tension
- Smooths expression lines
- Gentle mechanism
Related comparisons
Research and educational reference only. Not medical advice.